Pancreatic Cancer

>

Latest News

Investigators are assessing treatment with ELC-100 among patients with pancreatic neuroendocrine tumors as part of a phase 1/2 trial.
FDA Grants Orphan Drug Designation to ELC-100 in Pancreatic NETs

January 13th 2025

Investigators are assessing treatment with ELC-100 among patients with pancreatic neuroendocrine tumors as part of a phase 1/2 trial.

The decision follows safety data from the phase 1/2 LOKON001 trial evaluating LOAd703 in advanced pancreatic ductal adenocarcinoma.
LOAd703 Receives FDA Fast Track Designation for Pancreatic Cancer

January 13th 2025

Investigators of a phase 2a trial plan to include additional combination arms assessing treatment with IMM-1-104 across different patient populations.
IMM-1-104 Regimens Yield Promising Activity in Pancreatic Cancer

January 8th 2025

No dose-limiting toxicities were observed with upamostat combination therapy in patients with metastatic pancreatic cancer.
Upamostat Combo Demonstrates Tolerability in Metastatic Pancreatic Cancer

January 6th 2025

Gemcitabine plus capecitabine was found to elicit longer survival outcomes than capecitabine alone in patients with pancreatic adenocarcinoma.
Gemcitabine Combo May Prolong Survival in Pancreatic Adenocarcinoma

January 4th 2025

Latest CME Events & Activities

2025 GI Satellite Symposia in San Francisco

January 23-24, 2025

Register Now!

The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape

View More

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

View More

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

<1
...
1314151617